Table 2.
Clinical and epidemiologic characteristics of the 63 (out of 68) Mediterranean CL patients for who the Leishmania species was identified
| L. major n = 48 (76%) | L. tropica/killicki n = 9 (14%) | L. infantum n = 6 (10%) | |
|---|---|---|---|
| Median age years [IQ25–IQ75] | 39 [16.3–56.5] | 42 [12–57] | 56 [22–56] |
| Sex ratio (M/F) | 1.66 | 1.25 | 2 |
| Median length of stay in endemic area days [IQ25-IQ75] | 60 [30–90] | 60 [48–60] | 45 [30–75] |
| Occurrence of skin lesions (n/data available) | |||
| During the stay | 12/38 (32%) | 2/8 (25%) | 2/4 (50%) |
| ≤ 30 days after the return | 16/38 (42%) | 2/8 (25%) | 1/4 (25%) |
| > 1 to ≤ 3 months | 8/38 (21%) | 3/8 (37%) | 0/4 (0%) |
| > 3 months | 2/38 (5%) | 1/8 (13%) | 1/4 (25%) |
| Median days before seeking medical advice [IQ25-IQ75] | 90 [60–103] | 90 [90–12] | 180 [128–255] |
| Number of lesions (n/data available) | |||
| Unique | 18/47 (38%) | 5/9 (56%) | 3/6 (50%) |
| Multiple | 29/47 (62%) | 4/9 (44%) | 3/6 (50%) |
| Localization of lesions (n/data available) | |||
| Limb (at least one lesion) | 37/46 (80%) | 3/9 (33%) | 3/6 (50%) |
| Face (at least one lesion) | 9/46 (20%) | 6/9 (67%) | 3/6 (50%) |
| Crusted ulcero-necrotic lesions | 44/48 (92%) | 6/9 (67%) | 1/6 (17%) |
| Country of contamination | |||
| North- Africa (n = 37) | 24/37 (65%) | 9/37 (24%) | 4/37 (11%) |
| Algeria (n = 4) | 2/4 | – | 2/4 |
| Morocco (n = 8) | 4/8 | 2/8 | 2/8 |
| Tunisia (n = 25) | 18/25 | 7/25 | – |
| Sub-Saharan Africa (n = 20) | 20/20 (100%) | – | – |
| Mali (n = 3) | 3/3 | – | – |
| Mauritania (n = 6) | 6/6 | – | – |
| Senegal (n = 11) | 11/11 | – | – |
| Middle East (n = 4) | 4/4 (100%) | – | – |
| Egypt (n = 1) | 1/1 | – | – |
| Israel (n = 3) | 3/3 | – | – |
| Europe (n = 2) | – | – | 2/2 (100%) |
| Spain (n = 2) | – | – | 2/2 |